AlphaCrest Capital Management LLC - ALLOGENE THERAPEUTICS INC ownership

ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 171 filers reported holding ALLOGENE THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.29 and the average weighting 0.3%.

Quarter-by-quarter ownership
AlphaCrest Capital Management LLC ownership history of ALLOGENE THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$599,000
+146.5%
55,454
+160.6%
0.04%
+200.0%
Q2 2022$243,000
-46.2%
21,278
-57.1%
0.01%
-52.0%
Q1 2022$452,000
+12.2%
49,574
+83.4%
0.02%
+66.7%
Q4 2021$403,000
-81.0%
27,034
-66.7%
0.02%
-83.5%
Q2 2021$2,120,000
+268.7%
81,305
+398.8%
0.09%
+184.4%
Q1 2021$575,000
+99.7%
16,300
+43.0%
0.03%
+33.3%
Q4 2020$288,00011,4000.02%
Other shareholders
ALLOGENE THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Vida Ventures Advisors, LLC 1,798,163$46,213,00013.24%
Wildcat Capital Management, LLC 1,716,370$44,111,0005.71%
TPG Group Holdings (SBS) Advisors, Inc. 18,716,306$481,009,0004.77%
Copernicus Capital Management, LLC 15,000$386,0004.67%
Coastal Bridge Advisors, LLC 301,240$7,742,0001.79%
Lombard Odier Asset Management (Switzerland) SA 914,416$23,500,0001.46%
Casdin Capital, LLC 2,100,000$53,970,0001.34%
Pier Capital, LLC 450,182$11,570,0001.20%
Ghost Tree Capital, LLC 150,000$3,855,0001.13%
Sessa Capital IM, L.P. 750,000$19,275,0000.95%
View complete list of ALLOGENE THERAPEUTICS INC shareholders